Evidence map›Paper›PMID 31167361›Full record

ReviewViruses2019

Biological Function and Application of Picornaviral 2B Protein: A New Target for Antiviral Drug Development.

Zengbin Li, Zixiao Zou, Zeju Jiang, Xiaotian Huang, Qiong Liu

Open access · goldAbstract readReview
In one paragraph

Review in Viruses, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.4field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Zengbin LiSchool of Public Health, Nanchang University, Nanchang 330006, China. nculizengbin@163.com.
Zixiao ZouDepartment of Medical Microbiology, School of Medicine, Nanchang University, Nanchang 330006, China. zzx1019446427@163.com.
Zeju JiangJiangxi Medical College, Nanchang University, Nanchang 330006, China. jiangzeju1998@126.com.
Xiaotian HuangDepartment of Medical Microbiology, School of Medicine, Nanchang University, Nanchang 330006, China. xthuang@ncu.edu.cn.
Qiong LiuDepartment of Medical Microbiology, School of Medicine, Nanchang University, Nanchang 330006, China. p19890528@126.com.ORCID 0000-0002-8950-6133
Nanchang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Picornaviruses are associated with acute and chronic diseases. The clinical manifestations of infections are often mild, but infections may also lead to respiratory symptoms, gastroenteritis, myocarditis, meningitis, hepatitis, and poliomyelitis, with serious impacts on human health and economic losses in animal husbandry. Thus far, research on picornaviruses has mainly focused on structural proteins such as VP1, whereas the non-structural protein 2B, which plays vital roles in the life cycle of the viruses and exhibits a viroporin or viroporin-like activity, has been overlooked. Viroporins are viral proteins containing at least one amphipathic α-helical structure, which oligomerizes to form transmembrane hydrophilic pores. In this review, we mainly summarize recent research data on the viroporin or viroporin-like activity of 2B proteins, which affects the biological function of the membrane, regulates cell death, and affects the host immune response. Considering these mechanisms, the potential application of the 2B protein as a candidate target for antiviral drug development is discussed, along with research challenges and prospects toward realizing a novel treatment strategy for picornavirus infections.

Indexed as

Ion ChannelsAdaptive ImmunityAnimalsAntiviral AgentsApoptosisAutophagyCalcium ChannelsDrug DevelopmentHumansInflammasomesPicornaviridaePicornaviridae InfectionsReceptors, Pattern RecognitionVaccinesViral Nonstructural ProteinsViroporin ProteinsAntiviral AgentsCalcium ChannelsInflammasomesIon ChannelsReceptors, Pattern RecognitionVaccinesViral Nonstructural ProteinsViroporin Proteins2B proteindrug developmentpicornavirusviroporin

Identifiers

PMID31167361
PMCPMC6630369
OpenAlexW2948670761

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.